Best of heart failure

37 for cardiogenic shock. N Engl J Med. 1999;341(9):625 – 34. 16. Mehta RH, Grab JD, O'Brien SM, Glower DD, Haan CK, Gammie JS, et al. Clinical characteristics and in- hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardi- ac Database. Circulation. 2008;117(7):876 – 85. 17. •• Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419 – 32 The CULPRIT-SCHOCK trial showed that culprit-lesion-only PCI is superior to multivessel PCI in patients with AMI com- plicated by cardiogenic shock and evidence of multivessel disease on the initial angiogram. This superiority remains true at 1-year follow-up. 18. •• Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer- Saraei R, Fuernau G, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379(18):1699 – 710 The CULPRIT-SCHOCK trial showed that culprit-lesion-only PCI is superior to multivessel PCI in patients with AMI com- plicated by cardiogenic shock and evidence of multivessel disease on the initial angiogram. This superiority remains true at 1-year follow-up. 19. Kapur NK, Davila CD. Timing, timing, timing: the emerging concept of the ‘ door to support ’ time for cardiogenic shock. Eur Heart J. 2017;38(47):3532 – 4. 20. Esposito ML, Kapur NK. Acute mechanical circulatory support for cardiogenic shock: the “ door to support ” time. F1000Res. 2017;6:737. 21. Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circu- latory support in acute myocardial infarction compli- cated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454 – 61. 22. Annamalai SK, Buiten L, Esposito ML, Paruchuri V, Mullin A, Breton C, et al. Acute hemodynamic effects of intra-aortic balloon counterpulsation pumps in ad- vanced heart failure. J Card Fail. 2017;23(8):606 – 14. 23. Deppe AC, Weber C, Liakopoulos OJ, Zeriouh M, Slottosch I, Scherner M, et al. Preoperative intra-aortic balloon pump use in high-risk patients prior to coro- nary artery bypass graft surgery decreases the risk for morbidity and mortality-a meta-analysis of 9,212 pa- tients. J Card Surg. 2017;32(3):177 – 85. 24. O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. A prospective, random- ized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coro- nary intervention: the PROTECT II study. Circula- tion. 2012;126(14):1717 – 27. 25. Napp LC, Kuhn C, Hoeper MM, Vogel-Claussen J, Haverich A, Schafer A, et al. Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults. Clin Res Cardiol. 2016;105(4):283 – 96. 26. Kapur NK, Davila CD, Jumean MF. Integrating interventional cardiology and heart failure man- agement for cardiogenic shock. Interv Cardiol Clin. 2017;6(3):481 – 5. 4 Page 12 of 12 Curr Treat Options Cardio Med (2019) 21: 4